Psyched Wellness Ltd.

Recent News

  • Psyched Wellness Announces Participation in the H.C. Wainwright 23rd Annual Global Investment Conference

    Toronto, Ontario--(Newsfile Corp. - September 10, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce that CEO, Jeffrey Stevens and COO, David Shisel will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held virtually on September 13-15, 2021.A recording of Psyched's presentation will be available on-demand from Monday, September 13th at 7:00...

    2021-09-10 7:00 AM EDT
  • Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1

    Toronto, Ontario--(Newsfile Corp. - September 8, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce the Company, in collaboration with KGK, a licensed CRO in Canada, is commencing the next preclinical trial study on Amanita Muscaria Extract (AME-1). The trial will comprise a neurobehavioral study focusing on determining the neurotoxicity effects of AME-1 on functional...

    2021-09-08 7:00 AM EDT
  • Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding Its Work on the AME-1

    Toronto, Ontario--(Newsfile Corp. - August 17, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has submitted applications to the United States Patent and Trademark office, for four further provisional patents surrounding the Company's flagship product - AME-1.The applications were submitted on August 11, 2021 as such:App US63/232,144: THERAPEUTIC COMPOSITIONS OF...

    2021-08-17 7:30 AM EDT
  • Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1

    Toronto, Ontario--(Newsfile Corp. - July 26, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the Company has entered into a service agreement with CannaLabs, a Canadian, London-based laboratory services company, licensed by Health Canada.According to the agreement, Psyched Wellness will use the services of CannaLabs to perform stability tests on the Company's AME-1....

    2021-07-26 7:30 AM EDT
  • Psyched Wellness Announces Filing of Amended and Restated MD&A

    Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, announces that as a result of a continuous disclosure review conducted by staff of the Ontario Securities Commission, it is issuing the following press release to clarify its previous disclosure. The Company has refiled its annual management discussion and analysis ("MD&A") for the year ended...

    2021-07-22 4:15 PM EDT
  • Psyched Wellness Successfully Completes Its Largest Extraction and Shipment of AME-1 to Asia

    Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that the company has completed its largest extraction of AME-1 to date, and has successfully shipped it to the Company's contract research organization ("CRO") partner labs in Asia, in order to complete the pre-clinical studies and other scientific work...

    2021-07-22 7:30 AM EDT
  • Amanda Galbraith, Principal at Navigator Joins the Board of Psyched Wellness

    Toronto, Ontario--(Newsfile Corp. - July 7, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Amanda Galbraith has been appointed to its Board of Directors to drive its communications strategy.A trusted advisor to political leaders, CEOs, Board of Directors and executive teams, Amanda Galbraith is one of Canada's foremost crisis communications and public...

    2021-07-07 7:30 AM EDT
  • Psyched Wellness Receives Positive Results from It's 14-Day Oral Toxicity Preclinical Study

    Toronto, Ontario--(Newsfile Corp. - July 6, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional mushrooms, is pleased to announce the company has received the results from the 14-day oral toxicity preclinical study conducted by KGK Science, a licensed CRO in Canada. The significant information obtained from the test results showed no treatment-related adverse effects on treated animals during the study...

    2021-07-06 7:30 AM EDT